These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4671451)

  • 1. [ABO hemolytic disease of the newborn. Criteria for prognostic and therapeutic evaluation (except exsanguination transfusion)].
    Salvioli GP
    Pathologica; 1972; 64(935):309-14. PubMed ID: 4671451
    [No Abstract]   [Full Text] [Related]  

  • 2. [ABO hemolytic disease of the newborn. Treatment by exsanguination transfusion].
    Lange MM
    Pathologica; 1972; 64(935):315-24. PubMed ID: 4677646
    [No Abstract]   [Full Text] [Related]  

  • 3. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
    Osborn LM; Lenarsky C; Oakes RC; Reiff MI
    Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of washed group O erythrocytes suspended in 5% albumin administered in ABO group-related hemolytic disease of the newborn].
    Pedich M; Reperowicz-Iszczuk J; Maślińska T
    Pediatr Pol; 1975 Aug; 50(8):1023-7. PubMed ID: 1172227
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrence rate of ABO hemolytic disease of the newborn.
    Katz MA; Kanto WP; Korotkin JH
    Obstet Gynecol; 1982 May; 59(5):611-4. PubMed ID: 7070734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assistance to the premature infant with Rh hemolytic disease].
    Marini A; Caccamo ML
    Pathologica; 1972; 64(933):253-73. PubMed ID: 4210241
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of AB substance for the exsanguination transfusion in ABO system incompatibility].
    Ruttkay F; Fabian P; Calkovská Z
    Cesk Pediatr; 1972 Nov; 27(11):554-5. PubMed ID: 4673826
    [No Abstract]   [Full Text] [Related]  

  • 8. Complement in ABO--hemolytic disease of the newborn.
    Wang MY; Desforges JF
    Pediatrics; 1971 Oct; 48(4):650-3. PubMed ID: 5165506
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemolytic disease of the newborn from the viewpoint of the pediatrician].
    Janovský M; Polácek K
    Cesk Gynekol; 1969 Oct; 34(8):485-8. PubMed ID: 4982153
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood group and sex of infants treated with exchange transfusion for hemolytic ABO disease].
    Hodr R; Vondrácek J; Skutilová J
    Cesk Pediatr; 1988 Apr; 43(4):245-7. PubMed ID: 3396111
    [No Abstract]   [Full Text] [Related]  

  • 11. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 12. [A few remarks of the immunohematologist in connection with administration of exchange transfusions in the newborn with hemolytic disease (with respect to the transfusion material)].
    Kulich V; Sauer J
    Cesk Gynekol; 1969 Oct; 34(8):488-90. PubMed ID: 5354332
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hemolytic disease of the newborn].
    Nakayama K; Fujisawa S
    Rinsho Byori; 1967; ():Suppl 14:61-70. PubMed ID: 4969613
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neonatal hemolytic disease. II. Diagnostic, prognostic and therapeutic considerations on 24 cases of neonatal hemolytic disease caused by ABO factor isoimmunization].
    Saggese V; Di Marco A; Polito P
    Riv Clin Pediatr; 1967 Jan; 79(1):23-32. PubMed ID: 5628068
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of phototherapy in ABO hemolytic disease of the newborn.
    Bajpai PC; Misra PK; Das VK; Tripathi TK; Kapoor CL
    Indian J Med Res; 1973 Nov; 61(11):1658-65. PubMed ID: 4799677
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinico-statistical considerations on newborn infants treated with exchange transfusions for hemolytic disease caused by Rh isoimmunization or ABO incompatibility and for hyperbilirubinemia of non-immunological causes in full-term newborn infant. (Examination of 462 cases)].
    Di Piero G; Mencarini L; Ottaviano S; Lapi AS
    Riv Clin Pediatr; 1967; 80(4):89-112. PubMed ID: 4974851
    [No Abstract]   [Full Text] [Related]  

  • 18. [Hemolytic disease of newborn caused by anti-c antibody].
    Tóth A; Vágvölgyi E; Trézli I
    Orv Hetil; 1982 Aug; 123(32):1983-4. PubMed ID: 6815609
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemolytic disease of the newborn and therapeutic anti-allergic antibodies].
    Guimbretière J; Dehorne M; Guimbretière L
    Rev Fr Transfus; 1969; 12(1):Suppl:395+. PubMed ID: 4987784
    [No Abstract]   [Full Text] [Related]  

  • 20. [Erythropoietic activity in newborn infants with maternal-fetal incompatibility in the ABO system treated with exchange transfusion. Use of the Ashby method in 14 cases].
    Stegagno G; Mencarini L; Orvieto G
    Minerva Pediatr; 1968 Oct; 20(41):2131-42. PubMed ID: 5754726
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.